Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

7.7%

2 terminated out of 26 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

12%

3 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed with results

Key Signals

2 with results75% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (14)
P 2 (1)
P 3 (2)
P 4 (1)

Trial Status

Unknown11
Recruiting7
Completed6
Terminated2

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (26)

Showing 20 of 20 trials
NCT07040540Completed

Hemodynamic Effects of Intradermal Methylene Blue During Breast Surgery Under General Anesthesia

NCT06704945Phase 3Recruiting

No Axillary Surgical Treatment in Clinically Lymph Node Negative Patients on Ultrasonography After Neoadjuvant Chemotherapy

NCT07338721Recruiting

Does Ultrasound Guidance Axillary Incision Improve Sentinel Lymph Node Detection in Breast Cancer?

NCT06652672Not ApplicableRecruiting

Sentinel Node and Organ-sparing Surgery in Stage I Colon Carcinoma

NCT06120439Not ApplicableCompleted

Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node Biopsy

NCT03719833Completed

Sentinel Lymph Node Biopsy After Neoadjuvant Treatment in Breast Cancer Patents

NCT05774483Not ApplicableRecruiting

Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative

NCT06870903Not ApplicableRecruiting

Comparison of Transvaginal Paracervical and Transperitoneal Approaches in Lymphadenectomy During v-NOTES Surgery for Patients Diagnosed With Endometrial Cancer

NCT06212440Not ApplicableCompletedPrimary

Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant Chemotherapy

NCT06518135RecruitingPrimary

Axillary Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With Initial cN1 Breast Cancer

NCT05457842Phase 2TerminatedPrimary

A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery

NCT03833960CompletedPrimary

SLNB After Neoadjuvant Treatment in Node Positive Patients

NCT03200704Phase 3Completed

A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer

NCT05942170Not ApplicableUnknownPrimary

The Combination of Preoperative MRI and SLN in the Surgical Management of CC and EC

NCT05703295UnknownPrimary

Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients

NCT05512468Not ApplicableUnknown

Application of Preoperative Axillary Lymph Node Marking With Nano-Carbon in Breast Cancer Patients Before Neoadjuvant Chemotherapy

NCT04403867Recruiting

The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.

NCT03630653Not ApplicableTerminated

Sentinel Lymph Node Procedure in Ipsilateral Invasive Breast Cancer Relapse

NCT04986306Unknown

The Validation of Sentinel Lymph Node Biopsy After Neo-adjuvant Chemotherapy in Breast Cancer Patients

NCT04932460Not ApplicableUnknown

Contrast-enhanced Ultrasonography Combined With Blue Dye as Dual-tracer for Sentinel Lymph Node Biopsy

Scroll to load more

Research Network

Activity Timeline